Try our beta test site
1 study found for:    MM08-141
Show Display Options
Rank Status Study
1 Active, not recruiting Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bendamustine;   Drug: Doxorubicin;   Drug: Bortezomib;   Drug: Filgrastim

Study has passed its completion date and status has not been verified in more than two years.